作者
《颈动脉钙化病变神经介入诊疗中国专家共识》工作组,北京神经内科学会泛血管病分会,中国卒中学会神经介入分会(Expert Group of Chinese Expert Consensus on Neurointerventional Diagnosis and Treatment of Carotid Artery Calcification Lesions, Pan-Vascular Disease Branch of Beijing Neurology Society, Chinese Interventional Neuroradiology Society of Chinese Stroke Association )
摘要
《颈动脉钙化病变神经介入诊疗中国专家共识》由北京神经内科学会泛血管病分会联合中国卒中学会神经介入分会组织专家,基于当前颈动脉钙化病变诊疗的最新进展和循证医学证据编写。本共识详细阐述了颈动脉钙化病变的流行病学特征、病理机制及多模态影像学评估方法(如颈动脉超声、CTA、MRA、DSA及光学相干断层扫描),明确了动脉狭窄程度的量化标准。在治疗方面,本共识不仅讨论了非手术治疗、颈动脉内膜切除术、经颈动脉血运重建术等策略,还重点规范了颈动脉支架成形术的适应证、禁忌证、手术时机、手术步骤、支架选择、围手术期管理及长期随访方案等关键内容。本共识旨在为临床医师提供颈动脉钙化病变的规范化神经介入诊疗框架,以期改善此类患者的治疗效果和预后,降低其心脑血管事件风险,并为相关专业人员、社会工作者、政府管理机构、卫生事业管理人员、医药企业等提供参考和指导。Abstract: The Chinese Expert Consensus on Neurointerventional Diagnosis and Treatment of Carotid Artery Calcification Lesions was developed by experts organized jointly by the Pan-Vascular Disease Branch of Beijing Neurology Society and Chinese Interventional Neuroradiology Society of Chinese Stroke Association, based on the latest advances and evidence-based medical data in the diagnosis and treatment of carotid artery calcification lesions. This consensus comprehensively outlines the epidemiological characteristics, pathological mechanisms, and multi-modal imaging assessment methods (including carotid ultrasound, CTA, MRA, DSA, and optical coherence tomography) for carotid artery calcification lesions, and establishes quantitative criteria for the degree of arterial stenosis. For treatment, the consensus not only discusses strategies such as non-surgical management, carotid endarterectomy, and transcarotid artery revascularization but also specifically standardizes key aspects of carotid artery stenting. These include its indications, contraindications, procedural timing, procedural steps, stent selection, perioperative management, and long-term postoperative follow-up. The consensus aims to establish a standardized neurointerventional framework for clinicians, improve the treatment outcomes and prognosis these patients, reduce their cardiovascular and cerebrovascular risks, and serve as a vital reference for healthcare professionals, social workers, government agencies, healthcare administrators, and pharmaceutical enterprises.